| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ORACLE CORP | Director | Common Stock | 21.1K | $2.48M | $117.09 | May 31, 2024 | Direct |
| ORACLE CORP | Director | Restricted Stock Unit | 0 | $0 | $117.09 | May 31, 2024 | Direct |
| Cyclerion Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 14, 2022 | Direct | ||
| ORACLE CORP | Director | Stock Option | 0 | May 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ORCL | ORACLE CORP | May 31, 2024 | 3 | $0 | 4 | Jun 3, 2024 | Director |
| ORCL | ORACLE CORP | May 3, 2024 | 3 | -$1.48M | 4 | May 6, 2024 | Director |
| ORCL | ORACLE CORP | May 1, 2024 | 3 | -$1.85M | 4 | May 2, 2024 | Director |
| ORCL | ORACLE CORP | Nov 10, 2023 | 2 | -$525K | 4 | Nov 13, 2023 | Director |
| ORCL | ORACLE CORP | May 31, 2023 | 3 | $0 | 4 | Jun 2, 2023 | Director |
| ORCL | ORACLE CORP | Dec 22, 2022 | 1 | $0 | 4 | Dec 23, 2022 | Director |
| CYCN | Cyclerion Therapeutics, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| ORCL | ORACLE CORP | May 31, 2022 | 3 | $0 | 4 | Jun 2, 2022 | Director |
| CYCN | Cyclerion Therapeutics, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |
| ORCL | ORACLE CORP | May 31, 2021 | 3 | $0 | 4 | Jun 2, 2021 | Director |